VRC-HIVDNA009-00-VP

HIV DNA vaccine · National Institute of Allergy and Infectious Diseases (NIAID)

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for VRC-HIVDNA009-00-VP, covering 2021-10-14 to 2021-11-01. Get the full timeline:

Most recent: Clinical Trial Update: Safety of and Immune Response to a DNA HIV Vaccine (VRC-HIVDNA009-00-VP) in HIV Infected Individuals With Acute HIV Infection [Phase 1, Phase 2]

See pricing